Pharmaceutical Privately-held US drugmaker Protega Pharmaceuticals, which recently launched Roxybond (oxycodone hydrochloride), the first and only Food and Drug Administration (FDA)-approved abuse-deterrent immediate-release (IR) pain medication in the USA, is now collaborating with Wellgistics Health to support pharmacist education on abuse-deterrent pain management options and regulatory compliance as well as increase patient access to the drug for appropriately prescribed patients. 4 March 2025